Baidu
map

百万医护撤编、医生将自由执业?国务院文件力度大!

2016-10-27 大鹏 “医学界”微信号

导语:军队医院改革、医生自由执业这两个在医疗界“讳而不言”的话题,终于被提上了国家日程。近日,中共中央、国务院印发了《“健康中国2030”规划纲要》(以下简称《纲要》),并于10月25日全文公布。作为推进健康中国建设的行动纲领,《纲要》为今后15年里的中国医疗健康产业的布局指明了方向。这也是建国以来首次在国家层面提出的健康领域中长期战略规划。从这份文件中,我们看到许多非常重要的信息。尤其值得注意的

导语:军队医院改革、医生自由执业这两个在医疗界“讳而不言”的话题,终于被提上了国家日程。


近日,中共中央、国务院印发了《“健康中国2030”规划纲要》(以下简称《纲要》),并于10月25日全文公布。作为推进健康中国建设的行动纲领,《纲要》为今后15年里的中国医疗健康产业的布局指明了方向。这也是建国以来首次在国家层面提出的健康领域中长期战略规划。从这份文件中,我们看到许多非常重要的信息。尤其值得注意的是,文件第一次从国家层面将实现医生自由执业提上了日程。不仅如此,期待已久的军队医院改革,也被提上了国家日程。




今年可谓是医疗改革动作不断的一年,从前不久中央推出的“270个城市开展分级诊疗试点”、“医疗服务价格改革实施方案”、八省市成为医改试点省份等结合起来,再联系十八届三中全会决议、十三五卫生事业发展规划、全国卫生与健康大会,再结合本次“健康中国2030”规划纲要的定调,中国医改究竟将走向何方?


此次《纲要》的发布,至少释放出了以下几大信号:


1、中央空前重视、医改将大大提速


医改是老大难,政府真能快速推进吗?前不久召开的全国卫生与健康大会,包括习近平在内的中央七常委悉数出席,规格至高实属罕见,这也充分说明了中央高层对医改的重视。本次《纲要》也将医疗健康提升到了国家战略层面。考虑到习近平执政以来,说到做到、表现出了极强的行动力,其既往推动的反腐败、军队改革等难事儿均推进有力,相信医改也会得到极强的推动,从而大大提速。


医疗服务价格改革是医改的前提条件,今年发改委也发出了《关于贯彻落实推进医疗服务价格改革意见的通知》,要求各地在年底前制定并实施价格改革方案,并且还罕见地确定了时间表,这是一个医改加速的明确信号。预计今年年底到明年上半年,改革的各项配套政策都会逐步推出,改革进程也会大大提速。


2、将有数以百万的医务人员“没编儿”


随着当前医生薪酬制度改革的不断推进,未来公立医院逐渐取消编制,已经是大势所趋。此次《纲要》也涉及到人事、编制、薪酬等多个领域。


“落实医疗卫生机构用人自主权,全面推行聘用制,形成能进能出的灵活用人机制。”《纲要》中对于“全面推行聘用制”的阐述,再一次将全国医务人员所关心的“编制”问题摆上了桌面。随着我国公立医院改革不断深化,医疗服务比价关系也进一步理顺。可见,未来公立医院不纳入编制管理将会成为医改进入深水区后的又一破冰之举。


可以预见的是,未来的15年内,将会有数以百万的医务人员“没编儿”了。


3、军队医院改革被提上国家日程


今年是公立医院改革如火如荼的一年,去行政化、去编制等“重磅”措施不断出台,中央高层也对医改高度关注。在这样的背景下,部队医院改革也被提上了日程。对此,上海某军队医院的一名科主任不无感慨地表示,“从我在医学院上学时,就听说的军队医院改革,终于板上钉钉了。”


此次《纲要》中最为“浓墨重彩”的一笔,就是把军队医院改革提上了国家日程。具体怎么改呢?根据文件精神,具体做法是“推进军队医院参加城市公立医院改革、纳入国家分级诊疗体系工作”。由此可见,部队医院移交地方已经是箭在弦上。


4、医师自由执业“千呼万唤始出来”


纵览该《纲要》,其中特别值得关注的一句话是:积极探索医师自由执业、医师个体与医疗机构签约服务或组建医生集团。据《医学界》观察,这应该是“自由执业”首次出现在如此高规格的政策文件当中,被正式提上了国家日程。


医生自由执业,是医改至关重要的一环。只有从体制中解放医生,让他们自由流动与充分竞争,才能真正让市场来为医生定价,让好医生为医院带来高价值,从而改变医院靠药品供养的畸形现状,最终从根本上改变医患关系。从《纲要》中我们可以看到,在多点执业实行多年之后,国家正式将自由执业提上日程,这一点在医疗界受到了非常积极的肯定。


在“千呼万唤”之后,医师自由执业这最后一步终于要在未来15年这个阶段内迈出。


5、医务人员的收入将会提高


薪资待遇,往往是医务人员最关心的话题。三明医改的成功之处,就是在于建立起了具有强烈刺激性的新的医务人员薪酬体系。


《纲要》中明确提出,要“落实基层医务人员工资政策”、“建立符合医疗卫生行业特点的人事薪酬制度”。可以预见的是,人事薪酬制度改革将会在全国的公立医院开展。在接下来的医疗改革中,不光是医务人员的收入,医疗服务价格也将会有所提高。


6、社会办医将迎来新一轮利好


改革开放38年了,大部分行业都基本实现了市场化,唯独医疗行业是市场化之外的一个孤岛。在新医改的背景下,如何厘清政府和市场的边界,这一议题亟待破解。


丝毫不让人感到意外的是,跟以往诸多政策文件一样,这次《纲要》也提出了要“优化多元办医格局”、“优先支持社会力量办医”。此外,破除社会力量进入医疗领域的不合理限制和隐性壁垒也被写进了文件当中。


据观察,近年来,从医师多点执业、分级诊疗,再到今天的鼓励社会办医,民营医院的利好消息并不鲜见。这次《纲要》中再次明确要求相关职能部门要“简政放权”,可以预见,社会办医将会迎来新一轮利好。


7、政府将继续加大医疗投入


从经济上看,当前经济下行压力大,如果能够做好医疗改革,无疑对于刺激经济发展、刺激消费、推动经济转型意义重大。仔细研读该《纲要》,其对涉及全民医疗卫生的诸多领域提出了具体要求,政府对加大医疗卫生事业投入的决心,跃然纸上。在财力可以保证的情况下,相信会进一步扩大对于医疗的投入。


另外一个研究《新医改7年,6万亿花哪了?》。结果显示:政府2015年投入到医疗上的支出仅占政府支出的7.13%——可见政府还有很强的扩大投入的能力。


我们在前面说了,《纲要》是建国以来首次在国家层面提出的健康领域中长期战略规划,也是今后15年推进健康中国建设的行动纲领。健康是人民幸福的基础,也是百姓最关心的议题。中央提出的“健康中国2030”,符合以人为本的执政理念,贯穿了个体的全生命周期,以及对人民健康的全方位保护。从“医疗卫生”拓展到“大健康”,涉及多个行业、多个政府部门。


正因为这样,要将“健康中国2030”的顶层设计落地,是非常艰巨的使命。以往的公共卫生政策,就面临文件发布,贯彻执行力不足的的问题。“健康中国2030”,由谁协调,通过什么样的机制协调,都会影响落地。这就需要中央在局部(部门)利益和全局利益之间进行权衡。只有这样,医改才可能得到有力推进。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1646128, encodeId=7a2316461283a, content=<a href='/topic/show?id=080d5469e79' target=_blank style='color:#2F92EE;'>#执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54697, encryptionId=080d5469e79, topicName=执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a523305089, createdName=维他命, createdTime=Thu Nov 10 06:55:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744962, encodeId=cf881e4496250, content=<a href='/topic/show?id=d8298629690' target=_blank style='color:#2F92EE;'>#自由执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86296, encryptionId=d8298629690, topicName=自由执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=121a35484289, createdName=linlin2324, createdTime=Sun May 14 02:55:00 CST 2017, time=2017-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152999, encodeId=26c91529993b, content=保留观望态度, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edf51958773, createdName=jqdxxby@126.com, createdTime=Thu Nov 03 00:22:33 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151723, encodeId=8431151e234f, content=走起哦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2291960840, createdName=蓬莱阁, createdTime=Fri Oct 28 15:13:50 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151722, encodeId=4ee7151e2201, content=走起哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2291960840, createdName=蓬莱阁, createdTime=Fri Oct 28 15:13:41 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151493, encodeId=c96915149330, content=学习起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Thu Oct 27 11:00:39 CST 2016, time=2016-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151488, encodeId=a80a151488ae, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6ba1970085, createdName=今天明天, createdTime=Thu Oct 27 10:03:58 CST 2016, time=2016-10-27, status=1, ipAttribution=)]
    2016-11-10 维他命
  2. [GetPortalCommentsPageByObjectIdResponse(id=1646128, encodeId=7a2316461283a, content=<a href='/topic/show?id=080d5469e79' target=_blank style='color:#2F92EE;'>#执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54697, encryptionId=080d5469e79, topicName=执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a523305089, createdName=维他命, createdTime=Thu Nov 10 06:55:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744962, encodeId=cf881e4496250, content=<a href='/topic/show?id=d8298629690' target=_blank style='color:#2F92EE;'>#自由执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86296, encryptionId=d8298629690, topicName=自由执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=121a35484289, createdName=linlin2324, createdTime=Sun May 14 02:55:00 CST 2017, time=2017-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152999, encodeId=26c91529993b, content=保留观望态度, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edf51958773, createdName=jqdxxby@126.com, createdTime=Thu Nov 03 00:22:33 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151723, encodeId=8431151e234f, content=走起哦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2291960840, createdName=蓬莱阁, createdTime=Fri Oct 28 15:13:50 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151722, encodeId=4ee7151e2201, content=走起哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2291960840, createdName=蓬莱阁, createdTime=Fri Oct 28 15:13:41 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151493, encodeId=c96915149330, content=学习起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Thu Oct 27 11:00:39 CST 2016, time=2016-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151488, encodeId=a80a151488ae, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6ba1970085, createdName=今天明天, createdTime=Thu Oct 27 10:03:58 CST 2016, time=2016-10-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1646128, encodeId=7a2316461283a, content=<a href='/topic/show?id=080d5469e79' target=_blank style='color:#2F92EE;'>#执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54697, encryptionId=080d5469e79, topicName=执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a523305089, createdName=维他命, createdTime=Thu Nov 10 06:55:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744962, encodeId=cf881e4496250, content=<a href='/topic/show?id=d8298629690' target=_blank style='color:#2F92EE;'>#自由执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86296, encryptionId=d8298629690, topicName=自由执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=121a35484289, createdName=linlin2324, createdTime=Sun May 14 02:55:00 CST 2017, time=2017-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152999, encodeId=26c91529993b, content=保留观望态度, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edf51958773, createdName=jqdxxby@126.com, createdTime=Thu Nov 03 00:22:33 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151723, encodeId=8431151e234f, content=走起哦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2291960840, createdName=蓬莱阁, createdTime=Fri Oct 28 15:13:50 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151722, encodeId=4ee7151e2201, content=走起哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2291960840, createdName=蓬莱阁, createdTime=Fri Oct 28 15:13:41 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151493, encodeId=c96915149330, content=学习起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Thu Oct 27 11:00:39 CST 2016, time=2016-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151488, encodeId=a80a151488ae, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6ba1970085, createdName=今天明天, createdTime=Thu Oct 27 10:03:58 CST 2016, time=2016-10-27, status=1, ipAttribution=)]
    2016-11-03 jqdxxby@126.com

    保留观望态度

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1646128, encodeId=7a2316461283a, content=<a href='/topic/show?id=080d5469e79' target=_blank style='color:#2F92EE;'>#执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54697, encryptionId=080d5469e79, topicName=执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a523305089, createdName=维他命, createdTime=Thu Nov 10 06:55:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744962, encodeId=cf881e4496250, content=<a href='/topic/show?id=d8298629690' target=_blank style='color:#2F92EE;'>#自由执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86296, encryptionId=d8298629690, topicName=自由执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=121a35484289, createdName=linlin2324, createdTime=Sun May 14 02:55:00 CST 2017, time=2017-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152999, encodeId=26c91529993b, content=保留观望态度, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edf51958773, createdName=jqdxxby@126.com, createdTime=Thu Nov 03 00:22:33 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151723, encodeId=8431151e234f, content=走起哦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2291960840, createdName=蓬莱阁, createdTime=Fri Oct 28 15:13:50 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151722, encodeId=4ee7151e2201, content=走起哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2291960840, createdName=蓬莱阁, createdTime=Fri Oct 28 15:13:41 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151493, encodeId=c96915149330, content=学习起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Thu Oct 27 11:00:39 CST 2016, time=2016-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151488, encodeId=a80a151488ae, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6ba1970085, createdName=今天明天, createdTime=Thu Oct 27 10:03:58 CST 2016, time=2016-10-27, status=1, ipAttribution=)]
    2016-10-28 蓬莱阁

    走起哦!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1646128, encodeId=7a2316461283a, content=<a href='/topic/show?id=080d5469e79' target=_blank style='color:#2F92EE;'>#执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54697, encryptionId=080d5469e79, topicName=执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a523305089, createdName=维他命, createdTime=Thu Nov 10 06:55:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744962, encodeId=cf881e4496250, content=<a href='/topic/show?id=d8298629690' target=_blank style='color:#2F92EE;'>#自由执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86296, encryptionId=d8298629690, topicName=自由执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=121a35484289, createdName=linlin2324, createdTime=Sun May 14 02:55:00 CST 2017, time=2017-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152999, encodeId=26c91529993b, content=保留观望态度, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edf51958773, createdName=jqdxxby@126.com, createdTime=Thu Nov 03 00:22:33 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151723, encodeId=8431151e234f, content=走起哦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2291960840, createdName=蓬莱阁, createdTime=Fri Oct 28 15:13:50 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151722, encodeId=4ee7151e2201, content=走起哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2291960840, createdName=蓬莱阁, createdTime=Fri Oct 28 15:13:41 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151493, encodeId=c96915149330, content=学习起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Thu Oct 27 11:00:39 CST 2016, time=2016-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151488, encodeId=a80a151488ae, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6ba1970085, createdName=今天明天, createdTime=Thu Oct 27 10:03:58 CST 2016, time=2016-10-27, status=1, ipAttribution=)]
    2016-10-28 蓬莱阁

    走起哦

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1646128, encodeId=7a2316461283a, content=<a href='/topic/show?id=080d5469e79' target=_blank style='color:#2F92EE;'>#执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54697, encryptionId=080d5469e79, topicName=执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a523305089, createdName=维他命, createdTime=Thu Nov 10 06:55:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744962, encodeId=cf881e4496250, content=<a href='/topic/show?id=d8298629690' target=_blank style='color:#2F92EE;'>#自由执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86296, encryptionId=d8298629690, topicName=自由执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=121a35484289, createdName=linlin2324, createdTime=Sun May 14 02:55:00 CST 2017, time=2017-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152999, encodeId=26c91529993b, content=保留观望态度, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edf51958773, createdName=jqdxxby@126.com, createdTime=Thu Nov 03 00:22:33 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151723, encodeId=8431151e234f, content=走起哦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2291960840, createdName=蓬莱阁, createdTime=Fri Oct 28 15:13:50 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151722, encodeId=4ee7151e2201, content=走起哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2291960840, createdName=蓬莱阁, createdTime=Fri Oct 28 15:13:41 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151493, encodeId=c96915149330, content=学习起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Thu Oct 27 11:00:39 CST 2016, time=2016-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151488, encodeId=a80a151488ae, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6ba1970085, createdName=今天明天, createdTime=Thu Oct 27 10:03:58 CST 2016, time=2016-10-27, status=1, ipAttribution=)]
    2016-10-27 Guoxj3234

    学习起来

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1646128, encodeId=7a2316461283a, content=<a href='/topic/show?id=080d5469e79' target=_blank style='color:#2F92EE;'>#执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54697, encryptionId=080d5469e79, topicName=执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a523305089, createdName=维他命, createdTime=Thu Nov 10 06:55:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744962, encodeId=cf881e4496250, content=<a href='/topic/show?id=d8298629690' target=_blank style='color:#2F92EE;'>#自由执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86296, encryptionId=d8298629690, topicName=自由执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=121a35484289, createdName=linlin2324, createdTime=Sun May 14 02:55:00 CST 2017, time=2017-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152999, encodeId=26c91529993b, content=保留观望态度, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edf51958773, createdName=jqdxxby@126.com, createdTime=Thu Nov 03 00:22:33 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151723, encodeId=8431151e234f, content=走起哦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2291960840, createdName=蓬莱阁, createdTime=Fri Oct 28 15:13:50 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151722, encodeId=4ee7151e2201, content=走起哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2291960840, createdName=蓬莱阁, createdTime=Fri Oct 28 15:13:41 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151493, encodeId=c96915149330, content=学习起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Thu Oct 27 11:00:39 CST 2016, time=2016-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=151488, encodeId=a80a151488ae, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6ba1970085, createdName=今天明天, createdTime=Thu Oct 27 10:03:58 CST 2016, time=2016-10-27, status=1, ipAttribution=)]
    2016-10-27 今天明天

    期待

    0

相关资讯

看一看凌晨4点的美国诊所, 你就知道国内医院缺什么

这是凌晨四点时,全球排名第一的美国梅奥诊所,空荡荡的,一个人都没有。这是凌晨四点时,全中国排名第一的北京协和医院,一千余人已经排起了长长的队伍,等待挂号。他们中,很多人从零点就已经开始排队。1、国内的医院缺什么北京协和医院年接待患者约226万左右,员工总数4000多人。美国梅奥诊所年接待患者约116万左右,是协和的的一半;员工总数61100人,是协和的15倍。协和医院是国内众多医院的缩影。巨大的反

两票制真落地了,安徽下月执行!

昨日(10月8日),国庆节假期回来的第一个工作日,安徽省食药监局给我们带来重磅通知,印发了《安徽省公立医疗机构药品采购推行“两票制”实施意见》,并明确自2016年11月1日起执行。两票制落地,真的来了!今年4月26日,国务院正式发文,明确医改试点省份推广“两票制”,业界一片哗然的同时,大家最关心的是政策什么时候开始落实。按规定,今年之内“两票制”在国家医改试点省份必须落地。如今,安徽的两票制政

两票制文件即将发布!29省推进一览

有关两票制文件的专家会签本周已经结束,出台在即!与此同步的是,29省进展不一,请看整理汇总:自年初《国务院办公厅关于印发深化医药卫生体制改革2016年重点工作任务的通知》(国办发〔2016〕26号)要求“优化药品购销秩序,压缩流通环节,综合医改试点省份要在全省范围内推行两票制,积极鼓励公立医院综合改革试点城市推行两票制”以来,各省积极筹备两票制具体工作。国务院明确,医改试点省份要在全范围内推广

重磅!今后评职称大医院说了算!

关于医护职称的陈旧评聘方法,多年来一直被广大医护所诟病。今天,三甲传真传递一条消息:最近人社部下发通知指出:要合理下放职称的评审权限,发挥用人主体在职称评审中的主导作用,逐步推动符合条件的大型公立医院去自主评审职称。「查看原文,请关注三甲传真后,在后台回复通知」此消息进一步在人社部尹蔚民部长口中得到印证。日前,尹蔚民部长专门撰文指出:要深化医疗行业人事制度改革,创新人才使用评价机制,完善职称晋升体

中国医改迎来很大手笔!不再九龙治水!

九龙治水是中国医改迟迟得不到推进的一个重要原因,福建省这一举措无疑将会给步入深水区的中国医改,打开一个制度层面的突破口,也显示了国家层面推动医疗改革的决心。这不仅是福建医改下的“一剂猛药”,也是目前医改中最大的手笔,从根本上颠覆现有管理体制。福建医改迎来了史上最大的手笔,中国职能最完备、职权最大的医保办诞生了。“福建医改看三明,全国医改看福建。”9月28日,福建医改再次传来重磅消息:福建省委将涉及

坑爹的四个医院指标!

导语:“也许主持医改的官员看着那一项又一项合格的指标,志得意满,但多少的辛酸和无奈却是在这些账目之外,只不过这些辛酸和无奈是别人的。”昨天在网上看到一篇文章,说的是某医院医生因为剖腹产指标已满,拒收孕妇,结果被媒体曝光,相关人员被批评教育,并责成医院加强医德医风建设。该医院的剖腹产指标是谁定的,咱不知道。我只想说说我的一些亲身经历。平均住院费用近年的医改,把控费当成了重中之重,官老爷们认为,下了这

Baidu
map
Baidu
map
Baidu
map